Evidence map›Paper›PMID 12021255›Full record

ArticleThe Journal of cell biology2002

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.

Zhuqing Qu-Petersen, Bridget Deasy, Ron Jankowski, Makato Ikezawa, James Cummins, Ryan Pruchnic, John Mytinger, Baohong Cao, Charley Gates, Anton Wernig and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in The Journal of cell biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03633565 (A Comparative Study of Strategies for Management of Duchenne Myopathy in Assiut University Children Hospital), which is not on this map. Cited by 289 papers.

0numbers the graph read from it
0cells of the map it votes in
289citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03633565 phase4unknown statusnot on this mapstarted 2018, after this paper: background citation

A Comparative Study of Strategies for Management of Duchenne Myopathy in Assiut University Children Hospital

TypeinterventionalSponsorAssiut UniversityRan2018 to 2021Enrolled45ConditionsMyopathyArmsSildenafil (Phosphodiesterase inhibitors), Prednisolone (Steroids), Mesenchymal stem cell transplantation
3 · Its place in the literature

Who cites it

289 citing papers in PubMed.

  1. Article
  2. Muscle-specific ERRγ activation mitigates muscle atrophy after ACL injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Review
  4. Review
  5. Resident vascular Sca1iScience · 2024
    Article
  6. Stem Cells and Bone Tissue Engineering.Life (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

229 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhuqing Qu-PetersenGrowth and Development Laboratory, Children's Hospital of Pittsburgh, Department of Orthopaedic Surgery, University of Pittsburgh, PA 15260, USA.
Bridget Deasy
Ron Jankowski
Makato Ikezawa
James Cummins
Ryan Pruchnic
John Mytinger
Baohong Cao
Charley Gates
Anton Wernig
Johnny Huard

Funding

MATURATION DEPENDENT ADENOVIRAL INFECTIVITY OF MYOFIBERSP01AR045925 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUANG, LEAF · 1999 to 2003
$4.4M
NIAMS NIH HHS 1 P01 AR45925-01NIAMS NIH HHS P01 AR045925
6 · The paper itself

Abstract

Three populations of myogenic cells were isolated from normal mouse skeletal muscle based on their adhesion characteristics and proliferation behaviors. Although two of these populations displayed satellite cell characteristics, a third population of long-time proliferating cells expressing hematopoietic stem cell markers was also identified. This third population comprises cells that retain their phenotype for more than 30 passages with normal karyotype and can differentiate into muscle, neural, and endothelial lineages both in vitro and in vivo. In contrast to the other two populations of myogenic cells, the transplantation of the long-time proliferating cells improved the efficiency of muscle regeneration and dystrophin delivery to dystrophic muscle. The long-time proliferating cells' ability to proliferate in vivo for an extended period of time, combined with their strong capacity for self-renewal, their multipotent differentiation, and their immune-privileged behavior, reveals, at least in part, the basis for the improvement of cell transplantation. Our results suggest that this novel population of muscle-derived stem cells will significantly improve muscle cell-mediated therapies.

Indexed as

Stem Cell TransplantationAnimalsBiomarkersCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell DivisionCell SeparationDystrophinEndothelial Growth FactorsHematopoietic Stem Cell TransplantationIn Vitro TechniquesLymphokinesMiceMice, Inbred C57BLMice, Inbred mdxBiomarkersDystrophinEndothelial Growth FactorsLymphokinesNerve Growth FactorVascular Endothelial Growth Factor AVascular Endothelial Growth Factors

Identifiers

PMID12021255
PMCPMC2173424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.